Embryonic liver fordin is involved in glucose glycolysis of hepatic stellate cell by regulating PI3K/Akt signaling

被引:0
|
作者
Wei Tu [1 ,2 ]
Jin Ye [3 ,4 ]
Zhi-Jun Wang [3 ,4 ]
机构
[1] Department of Gastroenterology,Tongji Hospital,Tongji Medical College Huazhong University of Science and Technology
[2] Institute of Liver Diseases,Tongji Hospital,Tongji Medical College Huazhong University of Science and Technology
[3] Department of Gastroenterology,Union Hospital,Tongji Medical College Huazhong University of Science and Technology
[4] Institute of Liver Diseases,Union Hospital,Tongji Medical College Huazhong University of Science and Technology
基金
中国国家自然科学基金;
关键词
Liver fibrosis; Embryonic liver fordin; PI3K/ Akt signaling; Hepatic stellate cells; Glucose glycolysis;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
1002 ; 100201 ;
摘要
AIM To investigate the role of embryonic liver fordin(ELF) in liver fibrosis by regulating hepatic stellate cells(HSCs) glucose glycolysis.METHODS The expression of ELF and the glucose glycolysisrelated proteins were evaluated in activated HSCs. si RNA was used to silence ELF expression in activated HSCs in vitro and the subsequent changes in PI3K/Akt signaling and glucose glycolysis-related proteins were observed.RESULTS The expression of ELF increased remarkably in HSCs of the fibrosis mouse model and HSCs that were cultured for 3 wk in vitro. Glucose glycolysis-related proteins showed an obvious increase in the activated HSCs, such as phosphofructokinase, platelet and glucose transporter 1. ELF-si RNA, which perfectly silenced the expression of ELF in activated HSCs, led to the induction of glucose glycolysis-related proteins and extracellular matrix(ECM) components. Moreover, p Akt, which is an important downstream factor in PI3K/Akt signaling, showed a significant change in response to the ELF silencing. The expression of glucose glycolysisrelated proteins and ECM components decreased remarkably when the PI3K/Akt signaling was blocked by Ly294002 in the activated HSCs. CONCLUSION ELF is involved in HSC glucose glycolysis by regulating PI3K/Akt signaling.
引用
收藏
页码:8519 / 8527
页数:9
相关论文
共 50 条
  • [21] miR-126 Controls Hematopoietic Stem Cell Proliferation by Regulating PI3K/AKT Signaling
    Boccalatte, Francesco
    Gentner, Bernhard
    Giustacchini, Alice
    Saini, Massimo
    Restuccia, Umberto
    Lechman, Eric
    van Galen, Peter
    Bachi, Angela
    Dick, John E.
    Naldini, Luigi
    MOLECULAR THERAPY, 2012, 20 : S218 - S218
  • [22] TEEG Induced A549 Cell Autophagy by Regulating the PI3K/AKT/mTOR Signaling Pathway
    Shi, Lu
    Tu, Yijun
    Xia, Yu
    Ye, Siqi
    Ma, Chaozhi
    Liu, Yanwen
    You, Pengtao
    ANALYTICAL CELLULAR PATHOLOGY, 2019, 2019
  • [23] Capsaicin Attenuates Hepatic Stellate Cells Activation by Inhibiting the PI3K/AKT/mTOR Pathway
    Cai, Qihong
    Dai, Ninggao
    Xu, Liming
    Zhu, Qiandong
    Zhang, Qiyu
    Zhou, Qingqing
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (06): : 2989 - 2995
  • [24] Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K/AKT/GSK-3β signaling pathway and regulating intestinal flora distribution
    Wang, Xin
    Cao, Shuxia
    Huang, Yuan
    Li, Liangchang
    Xu, Dongyuan
    Liu, Lan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [25] Targeting of PI3K/AKT and MEK Signaling
    de Bono, J. S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S84 - S84
  • [26] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [27] PI3K/AKT signaling and systemic autoimmunity
    Patel, RK
    Mohan, C
    IMMUNOLOGIC RESEARCH, 2005, 31 (01) : 47 - 55
  • [28] PI3K signaling in cancer: beyond AKT
    Lien, Evan C.
    Dibble, Christian C.
    Toker, Alex
    CURRENT OPINION IN CELL BIOLOGY, 2017, 45 : 62 - 71
  • [29] PI3K/AKT signaling and systemic autoimmunity
    Rahul K. Patel
    Chandra Mohan
    Immunologic Research, 2005, 31 : 47 - 55
  • [30] PI3K/AKT signaling in tumorigenesis and angiogenesis
    Jiang, Bing-Hua
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (07) : 422 - 423